Deciphering Ampullary Cancer: Korean Researchers Identify Aggressive Subtype of Rare Disease
Where the bile duct and pancreatic duct meet to drain digestive juices into the duodenum, a rare and elusive malignancy can develop: ampullary...
Search results for "cancer research"
EZH1 Mutation 'Locks' Cancer-Fighting Genes to Fuel Thyroid Tumors, Study Finds
Cancer cells do not grow simply by switching on genes that drive proliferation; they can also lock away genes that keep normal cells from becoming...
Unmasking Glioblastoma’s Accomplice: Researchers Identify Hidden Protein Network Driving Brain Tumor Recurrence
"I had surgery and I even went through radiation—so why did it come back?" Families of glioblastoma patients face this...
South Korean Researchers Discover Compound That Destroys Chemo-Resistant Liver Cancer Cells
Cancer cells that no longer respond to chemotherapy present one of the most formidable challenges in oncology.
Korean Researchers Uncover New Clues to Enhance Chronic Myeloid Leukemia Treatment
Korean researchers have uncovered a biological mechanism that could significantly improve the efficacy of treatments...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR
Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...
The Hidden Danger in a Cancer Survivor’s Pantry: Ultra-Processed Foods
Research now suggests that dietary habits following cancer treatment are a critical factor in long-term survival.
"Supporting Breakthroughs in Pancreatic Cancer Research" NCT’s Jisung Donates 250 Million Won to Samsung Medical Center
Samsung Medical Center announced on the 5th that Jisung, a member of the SM Entertainment group NCT, has donated 250...
"Loneliness is Dangerous" Single-Person Households Have a 27% Higher Risk of Dying Before Age 65?
Research results have shown that single-person households have a significantly higher risk of early death compared to...
Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026
Yuhan Corporation has detailed the status and trial design of the ongoing Phase 1/2 clinical study for YH42946, an oral...